Navigation Links
Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force
Date:9/6/2011

ket Drivers 83

6.4.1 Low-Cost Skilled Labor 83

6.4.2 Increase in Generics 83

6.4.3 Product Patent Regime 83

6.4.4 Vertically Integrated Business Model 83

6.4.5 Strategic Partnerships 83

6.5 CMO Market Restraints 84

6.5.1 Increasing Competition from China 84

6.5.2 Time-Consuming Development Periods 84

6.5.3 Need for Robust Execution Strategy 84

6.5.4 Poor Intellectual Property Protection and Regulatory Framework 85

6.5.5 Threat of Counterfeit Medicines Originating from India 85

6.5.6 Varied Compliance With cGMP Guidelines Across the Nation 85

6.5.7 High Effective Tax Rates 85

6.6 Clinical Research Organization (CRO) Market Size and Growth in India 85

6.6.1 Major CRO Locations in India 86

6.6.2 Clinical Trials Registered in 2009 in India 86

6.7 Key Players – Foreign 88

6.7.1 Quintiles 88

6.7.2 Paraxel 88

6.7.3 Pharmaceutical Product Development (PPD) Inc. 89

6.8 Key Players – Domestic 89

6.8.1 SIRO Clinpharm Pvt Ltd 89

6.8.2 Veeda Clinical Research Ltd 90

6.8.3 GVK Biosciences Pvt Ltd 91

6.8.4 Ecron Acunova 92

6.8.5 Synchron Research Services Pvt Ltd 93

6.9 CRO Market Drivers 94

6.9.1 High Risks and Costs Associated With Drug Development 94

6.9.2 Escalating Cost of Clinical Trials 95

6.9.3 Increase in Multinational Sites to Conduct Clinical Trials Will Drive the Clinical Trials Market in India 96

6.9.4 Increased Patient Availability due to Major Diseases 97

6.9.5 Global Increase in the Number of Clinical Trials Conducted 97

6.9.6 Restructuring the R&D 98

6.9.7 Increased Screening Rates During R&D 99

6.9.8 Expiring Patents Pressurize Pharmaceutical Companies to Reduce Costs 99

6.10 CRO Market Restraints 99

6.10.1 Lack of Training for Clinical Trial Professionals 99

6.10.2 Quality of Clini
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Current and Emerging Drugs Have No Advantage Over Enbrel in Inhibiting/Slowing the Progression of Rheumatoid Arthritis
2. Revolution Health and EmergingMed Launch Cancer Clinical Trial Matching and Referral Service
3. Malaria Vaccine Developer Sanaria Inc. Receives the Technology Council of Marylands Emerging Company of the Year Award
4. Current and Emerging Drugs Continue to Struggle for Patient Share in the Treatment of Major Depressive Disorder
5. Emerging Therapies Could Help Ease The Chronic Symptoms of Atopic Dermatitis For Adults and Children
6. Surveyed Neurologists Anticipate That Less Than 30 Percent of Their Use of Emerging Oral Agents in Multiple Sclerosis Will be in the First Line
7. At Nearly $120 Million, The Hepatitis C Drug Market in Brazil is Among the Largest Emerging Pharmaceutical Markets for the Disease
8. PAREXEL International to Present at William Blair Emerging Growth Stock Conference
9. Patient-Targeted Messaging for Emerging Multiple Sclerosis Agents Needs to Highlight Efficacy and Preservation of Quality of Life
10. Frost & Sullivan Lauds Viatronix as European Medical Imaging Emerging Company of the Year
11. Cancer Drugs Emerging as Top Driver of Specialty Drug Spending
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... , March 30, 2015 ... My Diabetes Emergency Plan at the 2015 @NatHurricaneCon ... to be prepared to manage your #diabetes before emergencies ... (ACE) – the charitable, educational and scientific arm of ... joined forces with Lilly Diabetes to share the ...
(Date:3/30/2015)... 30, 2015  Check-Cap Ltd. (NASDAQ: CHEK ), ... development of a preparation-free ingestible imaging capsule that utilizes ... today that its CEO, Guy Neev , will ring ... day.  Neev and Check-Cap will participate in the closing ... public offering and simultaneous private placement which raised a ...
(Date:3/30/2015)... and ORANGEBURG, N.Y., March 30, 2015  Uroplasty, ... VSCI ) shareholders have voted at the ... to approve the previously announced agreement and plan ... "We are pleased with the outcome of today,s ... both shareholder groups for approving the merger agreement," ...
Breaking Medicine Technology:Preparation Is Personal for Those with Chronic Illnesses 2Preparation Is Personal for Those with Chronic Illnesses 3Preparation Is Personal for Those with Chronic Illnesses 4Check-Cap to Celebrate Initial Public Offering with NASDAQ Closing Bell Ceremony on March 31, 2015 2Check-Cap to Celebrate Initial Public Offering with NASDAQ Closing Bell Ceremony on March 31, 2015 3Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 2Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 3Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 4
... , EAST HANOVER, N.J., Oct. 12 Novartis Pharma AG ... rights to Fanapt(TM) (iloperidone), a new oral medication ... (FDA) for the acute treatment of adults with schizophrenia. Novartis ... early 2010. , As part of the agreement with ...
... 12 Hospira, Inc. (NYSE: HSP ), a leading ... the company will present at the Credit Suisse 18th Annual ... , The presentation is scheduled to begin at 8:00 a.m. ... will be available to all interested parties through a live ...
Cached Medicine Technology:Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia 2Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia 3Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia 4Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia 5Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia 6Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia 7Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia 8
(Date:3/31/2015)... CA (PRWEB) March 31, 2015 Dr. Poneh ... now offer patients valuable savings through new Spring specials. Dr. ... off the holiday celebration this year by taking advantage of ... , "Spring brings together friends and loved ones that ... media. We are pleased to offer solutions for a great ...
(Date:3/31/2015)... 31, 2015 A' Design Award and ... Bruker EVOQ by Daniel Dion has been announced as ... Scientific Instruments, Medical Devices and Research Equipment Design ... the creative mind behind the award winning Medical Product ... developed under the direction of Dr. Rohan Thakur and ...
(Date:3/31/2015)... 2015 According to a recent YouGov/Huffington ... Americans interviewed supported detox and abstinence, while only 19% ... methadone.(1) Although many within the healthcare community advocate for ... suggest that most Americans concur with Novus Medical ... drug use is a better approach than prescribing other ...
(Date:3/31/2015)... March 31, 2015 A team of ... polyphenol with anti-cancer properties, into mesothelioma cancer cells. Surviving ... research on its website. Click here to read ... the yellow color to the spice turmeric, has limited ... bioavailability. Biomaterials experts at Università di Napoli Federico II ...
(Date:3/31/2015)... TN (PRWEB) March 31, 2015 Dr. ... welcomes warmer temperatures and sunshine; however, it's important to be ... eye damage. Experts say more than 90 percent ... few precautions and wearing safety glasses. Dr. Shofner shares five ... this season. , 1) Yard Work. While using a lawn ...
Breaking Medicine News(10 mins):Health News:West Hollywood Cosmetic Dentist, Dr. Poneh Ghasri, is Now Offering Various Special Offers Just in Time for Spring 2Health News:Daniel Dion wins Golden in A' Medical Product Design Awards 2Health News:Novus Medical Detox Center Highlights Survey Findings: More Americans Support Detox and Rehab Over Methadone as Treatment for Heroin Addiction 2Health News:Novus Medical Detox Center Highlights Survey Findings: More Americans Support Detox and Rehab Over Methadone as Treatment for Heroin Addiction 3Health News:Novus Medical Detox Center Highlights Survey Findings: More Americans Support Detox and Rehab Over Methadone as Treatment for Heroin Addiction 4Health News:New Research Reveals Novel Delivery Method for Potential Mesothelioma Treatment, According to Surviving Mesothelioma 2Health News:Popular Springtime Activities That Could Cause Irreversible Eye Damage by Renowned Eye Surgeon Dr. Stewart Shofner 2Health News:Popular Springtime Activities That Could Cause Irreversible Eye Damage by Renowned Eye Surgeon Dr. Stewart Shofner 3Health News:Popular Springtime Activities That Could Cause Irreversible Eye Damage by Renowned Eye Surgeon Dr. Stewart Shofner 4
... cholesterol and high blood pressure in people who,ve had a ... attack, according to a study to be presented as part ... Neurology,s 61st Annual Meeting in Seattle, April 25 - May ... LDL cholesterol, low HDL cholesterol, high triglycerides, and high blood ...
... -- Traumatic brain injury (TBI), a complex ... among Veterans and has been called one of the ... TBI is wide-ranging. Among its goals: shedding light on ... screening and diagnosis; developing drugs to treat brain injury ...
... April 30, 2009) A unique mother-daughter study that ... shows that percent of breast water could be linked to ... , The findings, published online today in Lancet Oncology ... more about breast density, an inheritable characteristic known to be ...
... of a novel therapy that uses magnetic pulses to ... a promising alternative to medication. , The therapy is ... were presented today (April 29, 2009) during the annual ... , In a previous randomized controlled clinical study ...
... Washing Hands, Recognizing Symptoms Key to Prevent Spread , ... attention to symptoms of illness are just some of ... the risk from the swine flu (H1N1) outbreak, the ... )"This is a serious situation that has ...
... ... 9:00 a.m. EDT, ... 1-800-814-4860, ... invites analysts and investors to participate in a briefing on Wednesday, May 6, 2009, with ...
Cached Medicine News:Health News:Controlling Cholesterol, Blood Pressure Adds Up to Prevent Stroke 2Health News:Video: Turning Hope Into Reality - Traumatic Brain Injury Research at the VA 2Health News:Mother-daughter breast density study points way to earlier cancer risk assessment 2Health News:New therapy based on magnetic stimulation shows promise for non-drug treatment for migraine 2Health News:Red Cross Urges Families and Communities to Prepare During Swine Flu Outbreak 2Health News:Red Cross Urges Families and Communities to Prepare During Swine Flu Outbreak 3Health News:Conference Call Advisory - NUCRYST Pharmaceuticals Corp. Conference Call to Discuss 2009 First Quarter Results 2
... most powerful, comprehensive and most proven ... OfficeMate is the most widely used ... out of every three computerized eyecare ... of all your practice management needs ...
... management software for eyecare professionals- ... multi-tasking, multi-office practice management system, ... technology- Winx Pro is a ... you in effectively managing the ...
Easy-to-use and afforable practice management software. For more details, please contact First Insight....
... Working with over 2,500 ... proud to serve one ... client bases in the ... PM Ophthalmology, we are ...
Medicine Products: